Artivion | CRY - Należności Handlowe





Należności Handlowe Zmiana Data
Abbott USD 10.57B 171M 2025-12
Accuray USD 91.79M 7.07M 2024-09
AngioDynamics USD 44.43M 1.79M 2025-09
Artivion USD 103.68M 6.31M 2025-12
AtriCure USD 71.31M 4.66M 2026-03
Baxter International USD 1.7B 310M 2026-03
Becton, Dickinson and Co. USD 2.2B 303M 2026-03
Boston Scientific USD 2.93B 98M 2025-12
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Inogen USD 37.09M 4.11M 2024-06
Integra LifeSciences USD 264.41M 14.44M 2026-03
J&J USD 21.33B 3.72B 2025-12
Mesa Laboratories USD 40.23M 4.66M 2024-09
Orthofix International USD 135.75M 4.94M 2025-12
Pfizer USD 16.17B 332M 2026-03
ResMed USD 998.84M 13.2M 2026-03
Stryker USD 3.57B 468M 2026-03
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 365.53M 19.94M 2026-03
Terumo JPY 217.57B 2.28B 2026-03
Trinity Biotech USD 15.02M 3.7M 2025-09